Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wiley A Schell

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Infection and Immunity|July 5, 2023
Susceptibility to Cryptococcus neoformans Infection with Bruton's Tyrosine Kinase InhibitionJulia A Messina, Charles D Giamberardino, Jennifer L Tenor, et al.
Plos Pathogens|September 24, 2013
Quantitative models of the dose-response and time course of inhalational anthrax in humansDamon J A Toth, Adi V Gundlapalli, Wiley A Schell, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 1, 2018
Genomic characterization of recurrent mold infections in thoracic transplant recipientsJulia A Messina, Cameron R Wolfe, Marion Hemmersbach-Miller, et al.
Infection and Immunity|January 31, 2014
Impact of surfactant protein D, interleukin-5, and eosinophilia on CryptococcosisStephanie M Holmer, Kathy S Evans, Yohannes G Asfaw, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious diseaseLeah E Cowen, Sheena D Singh, Julia R Köhler, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against CryptococcusKaren Joy Shaw, Wiley A Schell, Jonathan Covel, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2018
Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infantsJulie Autmizguine, P Brian Smith, Kristi Prather, et al.
JAMA Internal Medicine|February 5, 2014
Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacyRebekah W Moehring, Sarah S Lewis, Pamela J Isaacs, et al.
Mbio|April 15, 2024
A ketogenic diet enhances fluconazole efficacy in murine models of systemic fungal infectionJulia R Palmucci, Blake E Sells, Charles D Giamberardino, et al.
Mbio|October 12, 2022
Efficacy of APX2039 in a Rabbit Model of Cryptococcal MeningitisCharles D Giamberardino, Wiley A Schell, Jennifer L Tenor, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Infection and Immunity|July 5, 2023
Susceptibility to Cryptococcus neoformans Infection with Bruton's Tyrosine Kinase InhibitionJulia A Messina, Charles D Giamberardino, Jennifer L Tenor, et al.
Plos Pathogens|September 24, 2013
Quantitative models of the dose-response and time course of inhalational anthrax in humansDamon J A Toth, Adi V Gundlapalli, Wiley A Schell, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 1, 2018
Genomic characterization of recurrent mold infections in thoracic transplant recipientsJulia A Messina, Cameron R Wolfe, Marion Hemmersbach-Miller, et al.
Infection and Immunity|January 31, 2014
Impact of surfactant protein D, interleukin-5, and eosinophilia on CryptococcosisStephanie M Holmer, Kathy S Evans, Yohannes G Asfaw, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2009
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious diseaseLeah E Cowen, Sheena D Singh, Julia R Köhler, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
<i>In Vitro</i> and <i>In Vivo</i> Evaluation of APX001A/APX001 and Other Gwt1 Inhibitors against CryptococcusKaren Joy Shaw, Wiley A Schell, Jonathan Covel, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2018
Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infantsJulie Autmizguine, P Brian Smith, Kristi Prather, et al.
JAMA Internal Medicine|February 5, 2014
Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacyRebekah W Moehring, Sarah S Lewis, Pamela J Isaacs, et al.
Mbio|April 15, 2024
A ketogenic diet enhances fluconazole efficacy in murine models of systemic fungal infectionJulia R Palmucci, Blake E Sells, Charles D Giamberardino, et al.
Mbio|October 12, 2022
Efficacy of APX2039 in a Rabbit Model of Cryptococcal MeningitisCharles D Giamberardino, Wiley A Schell, Jennifer L Tenor, et al.
Pageof 5